Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00601055 · ClinicalTrials.gov registry record · NA

Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease

A NA study of Depression and Pulmonary Disease, Chronic Obstructive, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
101
Enrollment target
2
Study locations

NCT00601055: Completed NA study of Depression and Pulmonary Disease, Chronic Obstructive, sponsored by Weill Medical College of Cornell University.

NCT00601055 is a NA study of Depression and Pulmonary Disease, Chronic Obstructive that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 101 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00601055, a NA study of Depression and Pulmonary Disease, Chronic Obstructive, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
101 participants
Enrollment target
2
Study locations

Study Summary

This study will evaluate the effectiveness of problem-solving therapy combined with treatment adherence procedures in treating older people with major depression and chronic obstructive pulmonary disease.

Interventions

  • BEHAVIORAL Problem Solving-Rx Adherence (PSA)
  • BEHAVIORAL PID-C

Study Locations (2)

New York

  • The Burke Rehabilitation Hospital - White Plains
  • Weill Medical College of Cornell University - White Plains

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2008-02
Est. Completion 2015-08
Phase NA

What the finished NCT00601055 record still lists

NCT00601055 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower).

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Problem Solving-Rx Adherence (PSA) is the first listed.

NCT00601055 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00601055 about?

NCT00601055 is a clinical study titled "Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease". This study will evaluate the effectiveness of problem-solving therapy combined with treatment adherence procedures in treating older people with major depression and chronic obstructive pulmonary disease.

What is the current status of trial NCT00601055?

This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2008-02. Estimated completion is 2015-08.

What conditions does trial NCT00601055 study?

This clinical trial studies the following conditions: Depression, Pulmonary Disease, Chronic Obstructive.

What interventions are being tested in trial NCT00601055?

The interventions under investigation include: Problem Solving-Rx Adherence (PSA) (BEHAVIORAL), PID-C (BEHAVIORAL).

Who is sponsoring clinical trial NCT00601055?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00601055 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00601055's enrollment target sits among peer trials

101 324th of 679 higher than 355 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04033497 · 101 participants · NA

    Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases

  • NCT05111574 · 101 participants · Phase 2

    Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

  • NCT05984680 · 101 participants

    COPD Care Pathway Among Patients With Cancer

  • NCT06266299 · 101 participants · Phase 1

    A Study of KK2269 in Adult Participants With Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00601055, the US trial registry maintained by the National Library of Medicine. NCT00601055 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.